Los Angeles City Attorney Mike Feuer has reached a settlement with a California company accused of advertising and selling an at-home test for COVID-19 despite a lack of approval from the U.S. Food and Drug Administration for any at-home test. 

Yikon Genomics Inc. and Brandon Hensinger, the CEO of the Foster City, California-based company, have agreed to cease marketing and selling test kits and to provide full refunds to any consumers who purchased them. According to a complaint filed Friday in Los Angeles Superior Court, Yikon and Hensinger registered the domain “thecoronavirustestkit.com” and advertised a “SARS-COV-2 IgG/IgM Home Screening Kit” for sale for $39 as concerns about the virus increased in the U.S. According to the complaint, the site, which as of Monday afternoon was no longer publicly accessible, claimed that the screening test used a “simple finger stick procedure” to test for COVID-19 antibodies in the bloodstream to detect a current or recent infection of the virus behind the current global pandemic.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]